MX9102701A - Derivados de 2-acilamido de 3,4-dihidro-3-oxo-quinoxalina que tienen actividad farmaceutica. - Google Patents
Derivados de 2-acilamido de 3,4-dihidro-3-oxo-quinoxalina que tienen actividad farmaceutica.Info
- Publication number
- MX9102701A MX9102701A MX9102701A MX9102701A MX9102701A MX 9102701 A MX9102701 A MX 9102701A MX 9102701 A MX9102701 A MX 9102701A MX 9102701 A MX9102701 A MX 9102701A MX 9102701 A MX9102701 A MX 9102701A
- Authority
- MX
- Mexico
- Prior art keywords
- quinoxalina
- acilamido
- dihidro
- oxo
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
- C07C233/15—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/38—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63113990A | 1990-12-20 | 1990-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9102701A true MX9102701A (es) | 1992-06-01 |
Family
ID=24529936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9102701A MX9102701A (es) | 1990-12-20 | 1991-12-19 | Derivados de 2-acilamido de 3,4-dihidro-3-oxo-quinoxalina que tienen actividad farmaceutica. |
Country Status (6)
| Country | Link |
|---|---|
| AU (1) | AU9049391A (es) |
| IE (1) | IE914452A1 (es) |
| MX (1) | MX9102701A (es) |
| PT (1) | PT99899A (es) |
| WO (1) | WO1992011245A1 (es) |
| ZA (1) | ZA9110018B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2138026C (en) * | 1992-06-22 | 2003-09-09 | Eckard Weber | Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists |
| FR2707643B1 (fr) * | 1993-07-16 | 1995-08-11 | Rhone Poulenc Rorer Sa | Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant. |
| WO1995009159A1 (en) * | 1993-09-28 | 1995-04-06 | Otsuka Pharmaceutical Company, Limited | Quinoxaline derivative as antidiabetic agent |
| US5631373A (en) | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
| US5801183A (en) * | 1995-01-27 | 1998-09-01 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists |
| NZ503076A (en) * | 1997-09-01 | 2002-10-25 | Kyorin Seiyaku Kk | 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives and addition salts thereof, with antagonism against amino acid receptors (particularly AMPA receptor) and processes for their preparation |
| JP2002516904A (ja) | 1998-06-03 | 2002-06-11 | ジーピーアイ ニル ホールディングス インコーポレイテッド | Ｎ−複素環式カルボン酸またはカルボン酸等配電子体のｎ−結合スルホンアミド |
| JP2000309586A (ja) | 1999-02-26 | 2000-11-07 | Kyorin Pharmaceut Co Ltd | ６−置換−７−ヘテロキノキサリンカルボン酸誘導体とその付加塩及びそれらの製造方法 |
| US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
| US6417189B1 (en) | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
| CA2393466C (en) | 1999-12-21 | 2010-01-19 | Gpi Nil Holdings, Inc. | Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| FR2827599A1 (fr) * | 2001-07-20 | 2003-01-24 | Neuro3D | Composes derives de quinoleine et quinoxaline,preparation et utilisations |
| DE10153345A1 (de) * | 2001-10-29 | 2003-05-08 | Gruenenthal Gmbh | Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen |
| SE0302324D0 (sv) * | 2003-08-28 | 2003-08-28 | Astrazeneca Ab | Novel compounds |
| WO2005056547A2 (en) * | 2003-12-04 | 2005-06-23 | Vertex Pharmaceuticals Incorporated | Quinoxalines useful as inhibitors of protein kinases |
| JP2011505367A (ja) * | 2007-11-30 | 2011-02-24 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | プロリルヒドロキシラーゼ阻害剤 |
| US20100305133A1 (en) * | 2007-11-30 | 2010-12-02 | Smithkline Beecham Corporation | Prolyl Hydroxylase Inhibitors |
| US8889683B2 (en) * | 2010-09-27 | 2014-11-18 | Merck Sharp & Dohme Corp. | Substituted quinoxalines as inhibitors of fatty acid binding protein |
| RU2744429C1 (ru) * | 2020-05-02 | 2021-03-09 | Андрей Александрович Иващенко | Противо-РНК вирусное, в том числе противокоронавирусное средство - замещенный хиноксалин, фармацевтическая композиция и применения |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0008864A1 (en) * | 1978-08-15 | 1980-03-19 | FISONS plc | Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| GR72941B (es) * | 1978-10-20 | 1984-01-16 | Lilly Co Eli | |
| US4252954A (en) * | 1979-10-25 | 1981-02-24 | Eli Lilly And Company | Salts of dihalo-3,4-dihydro-3-oxo-2-quinoxaline carboxylic acids and hindered amines |
-
1991
- 1991-11-22 AU AU90493/91A patent/AU9049391A/en not_active Abandoned
- 1991-11-22 WO PCT/US1991/008586 patent/WO1992011245A1/en active Application Filing
- 1991-12-19 IE IE445291A patent/IE914452A1/en not_active Application Discontinuation
- 1991-12-19 MX MX9102701A patent/MX9102701A/es unknown
- 1991-12-19 ZA ZA9110018A patent/ZA9110018B/xx unknown
- 1991-12-20 PT PT9989991A patent/PT99899A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IE914452A1 (en) | 1992-07-01 |
| WO1992011245A1 (en) | 1992-07-09 |
| PT99899A (pt) | 1993-01-29 |
| AU9049391A (en) | 1992-07-22 |
| ZA9110018B (en) | 1993-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9102473A (es) | Agentes farmaceuticos. | |
| FI921060A0 (fi) | Farmaceutiska aerosolformuleringar. | |
| FI922958A0 (fi) | Farmaceutisk sammansaettning. | |
| FI922252A0 (fi) | Farmaceutisk sammansaettning. | |
| FI922316A0 (fi) | Farmaceutisk sammansaettning. | |
| DE68911473D1 (de) | Arzneimittelformulierungen. | |
| FI923581A0 (fi) | Farmaceutisk kombinationsformation. | |
| FI923273A0 (fi) | Med dubbelminne foersett multiprocessorsystem. | |
| FI903382A0 (fi) | Topiskt anbringbara farmaceutiska preparat. | |
| MX9205981A (es) | Administracion transdermica de melatonina. | |
| NO912799L (no) | Foradditiver for droevtyggere. | |
| MX9102701A (es) | Derivados de 2-acilamido de 3,4-dihidro-3-oxo-quinoxalina que tienen actividad farmaceutica. | |
| MX9202839A (es) | 4-aminoquinolinas y composiciones farmaceuticas de las mismas. | |
| MX9201154A (es) | Derivados novedosos de 2-carboxiindoles que tienen actividad farmaceutica. | |
| DE69115263T2 (de) | Pharmazeutische zusammensetzungen. | |
| ITRM920237A1 (it) | Perfezionato impiego di medicinali broncodilatatori b2. | |
| FI925778A (fi) | Farmaceutiskt aktiva bensokinazolinfoereningar | |
| FI893643A0 (fi) | Farmaceutiska kompositioner. | |
| DZ1559A1 (fr) | Compositions pharmaceutiques. | |
| NO911429D0 (no) | Stoffbehandling. | |
| FR2663326B2 (fr) | Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant. | |
| DZ1926A1 (fr) | Formulations pharmaceutiques. | |
| MX9200532A (es) | Agente farmaceuticos. | |
| NO911430L (no) | Stoffbehandlingsmetode. | |
| MX9204370A (es) | Derivados de pirazol. |